世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028596

ヨルダンにおける医療、規制、および医療費償還制度の展望

GlobalData

Jordan - Healthcare, Regulatory and Reimbursement Landscape

発刊日 2020/12/31

言語英語

体裁PDF/113ページ

「PDF」版113ページ

0000028596

ヨルダンにおける医療、規制、および医療費償還制度の展望
Jordan - Healthcare, Regulatory and Reimbursement Landscape

1,995 USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、ヨルダンにおける医療、規制、および医療費償還制度の展望に関する情報や分析に不可欠な情報を提供し、医療市場における主要動向を明らかにします。また、人口動態、規制、医療費償還制度の展望、および医療インフラに関する見識を提供します。さらに、製薬および医療機器市場の動向やセグメントに関する貴重な情報を提供します。

最も重要なこととして、本レポートは、製薬および医療機器市場のトレンドとセグメンテーションに対する貴重な洞察を提供します。GlobalData社の業界専門家チームによる独自のデータベース、二次調査、社内分析からのデータと情報を使用して構築されています。

ヨルダンの医薬品市場は、2011年の65.億ドルから2019年には15.9億ドルに増加し、複合年間成長率(CAGR)は11.87%でした。市場全体では、2025年には31.3億ドルになると予測されています。高齢人口の増加とそれに伴う疾病負担の増加が医薬品市場の成長を牽引すると予想されます。ヨルダンの医療機器市場は2015年には2億2220万ドルでしたが、CAGR7.5%で増加し、2019年には2億9680万ドルに達し、2022年には3億6860万ドルに達する見込みです。ヨルダンの製薬業界は、ヘルスケア分野のデジタル化に向けて動き出しています。ヨルダン経済成長計画(JEGP)(2018-2022)では、ヘルスケアサービスの持続可能性、質、安全性の向上、メディカルツーリズムへの投資促進、国内製薬産業の支援を目指しています。

■調査範囲

  • 市場規模、市場セグメント、主要推進要因、および障壁など、ヨルダンにおける製薬および医療機器市場の概説
  • 主要企業のプロファイルとSWOT分析
    ➣ 主要製薬企業:Pfizer、Novartis、GlaxoSmithKline、Sanofi、JPM
    ➣ 主要医療機器企業:Abbott、Medtronic、GE Healthcare、Fresenius、Roche Diagnostics
  • COVID-19疫学、COVID-19の影響とヘルスケア市場の進展、HealthTech展望、償還と規制展望に関する洞察に富んだレビュー、国のヘルスケア償還プロセス、規制当局、新薬と医療機器の承認プロセスの詳細をカバーする分析
  • ヘルスケア償還プロセス、規制機関、新薬および医療機器の承認プロセスの詳細を含む、償還および規制状況の洞察を深めたレビュー
  • 最近の医療政策、医療インフラおよび医療費に関する情報
  • ヨルダンの医療市場における成長の機会と成長の課題の概要

レポート詳細

目次

1. Table of Contents
1.1 LIST OF FIGURES
1.2 LIST OF TABLES

2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights: Facts about the Jordanian Healthcare Market
2.3 Key Highlights: Healthcare Startups in Jordan
2.4 Key Events: Jordanian Pharmaceutical News, 2014-2020
2.5 Key Events: Jordanian Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Jordan, 2019

3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Jordan
3.5 Pharmaceutical Market - Market Segments
3.6 COVID-19 Epidemiology, Jordan
3.7 COVID-19 Impact and Developments, Jordan
3.8Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers

6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Jordan, 2019-2020

7. HealthTech Landscape
7.1 HealthTech Landscape, Jordan
7.2 HealthTech Deals Landscape, Jordan
7.3 Adoption of Technology in Healthcare, Jordan
7.4 Key HealthTech Deals, Jordan
7.5 Key Developments: Applications for Dealing with the COVID-19 Crisis, Jordan
7.6 Digital Health Benefits and Risks, Jordan

8. Market Access
8.1 Overview of Healthcare System, Jordan
8.2 Reimbursement Process, Jordan
8.3 Overview of Insurance Providers, Jordan
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Jordan
8.5 Pricing Policies, Jordan
8.6 Regulatory Landscape, Jordan
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, Jordan
8.6.3 Market Authorization for Medical Devices, Jordan
8.6.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing, Jordan
8.6.5 Intellectual Property Rights, Patent, Jordan
8.6.6 Intellectual Property Rights, Trademark, Jordan
8.6.7 Clinical Trials Regulation, Jordan
8.6.8 Pharmaceutical Clinical Trials Landscape, Jordan
8.6.9 Medical Devices Clinical Trials Landscape, Jordan
8.6.10 Pharmaceutical Advertisement Regulations, Jordan
8.6.11 Pharmacy Regulations, Jordan
8.6.12 Labeling and Packaging Regulations, Jordan

9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Jordan
9.2 Healthcare Facilities, Jordan
9.4 Life Expectancy and Immunization Rate, Jordan
9.5 Environmental Health, Jordan
9.6 Healthcare Personnel, Jordan
9.7 Disease Burden, Jordan
9.8 Healthcare Expenditure, Jordan

10 Trade Associations, Jordan

11 Trade Fairs, Jordan

12 Opportunities and Challenges

13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About GlobalData
13.4 Contact Us
13.5 Disclaimer

List of Tables
Table 1: COVID-19 Indicators (Number of Cases), Global and Jordan, 2020
Table 2: Health Insurance, Jordan, 2019
Table 3: Drug Pricing, Jordan, 2019
Table 4: Pricing Provisions for Generic and Originator, Jordan, 2019
Table 5: Patent Fee, Jordan, 2019
Table 6: Trademark Fees, Jordan, 2019
Table 7: Product Insert (Leaflet) Information, Jordan, 2019
Table 8: Label on the Blister Package, Jordan, 2019
Table 9: Label of Small Pack (2mL Pack and Below), Jordan, 2019
Table 10: Trade Associations, Jordan
Table 11: Conferences and Trade Fairs, Jordan, 2020-2021

List of Figures
Figure 1: Pharmaceutical Market, Jordan, Revenue ($B), 2011-2019
Figure 2: Medical Devices Market, Jordan, Revenue ($B), 2015-2022
Figure 3: Healthcare Startups in Jordan, 2020
Figure 4: Country Profile, Jordan, 2019
Figure 5: Pharmaceutical Market, Jordan, Revenue ($B), 2011-2018
Figure 6: Pharmaceutical Market, Jordan, Revenue Forecast ($B), 2019-2025
Figure 7: Pharmaceutical Exports ($B), Jordan, 2010-2019
Figure 8: Top Export Partners, Jordan, 2019
Figure 9: Pharmaceutical Imports ($B), Jordan, 2010-2019
Figure 10: Top Import Partners, Jordan, 2019
Figure 11: Ministry of Health Distribution Process, Jordan, 2019
Figure 12: Private Sector Distribution Process, Jordan, 2019
Figure 13: COVID-19 (Number of Cases), Jordan, 2020
Figure 14: COVID-19 (Number of Deaths), Jordan, 2020
Figure 15: Pharmaceutical Market, Major Players, 2019
Figure 16: Medical Devices Market, Jordan, Revenue ($B), 2015-2020
Figure 17: Medical Devices Market, Jordan, Revenue ($B) of Major Companies, 2019
Figure 18: Deal Value and Deal Count, Pharmaceutical Market, Jordan, 2019-2020
Figure 19: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Jordan, 2019-2020
Figure 20: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Jordan, 2019-2020
Figure 21: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Jordan, 2019-2020
Figure 22: Deal Value ($M), HealthTech, Jordan, 2019-2020
Figure 23: Deal Count (Number of Deals), HealthTech, Jordan, 2019-2020
Figure 24: Overview of Healthcare System, Jordan, 2020
Figure 25: Addition of Drug in JNDF, Jordan, 2020
Figure 26: Out-of-Pocket Spending (% of Current Health Expenditure), Jordan, 2010-2018
Figure 27: Annual Rate of Change (%), Consumer Price Index, Jordan, 2010-2019
Figure 28: Organization Structure of Regulatory Agencies, Jordan, 2019
Figure 29: New Drug Approval Process, Jordan, 2019
Figure 30: Medical Device Approval Process, Jordan, 2019
Figure 31: Licensing Process, Jordan, 2019
Figure 32: Patent Approval Process, Jordan, 2019
Figure 33: Trademark Approval Process, Jordan, 2019
Figure 34: Pharmaceutical Clinical Trials Count by Trial Status, Jordan, 2019-2020
Figure 35: Pharmaceutical Clinical Trials Count by Phase, Jordan, 2019-2020
Figure 36: Pharmaceutical Clinical Trials Count by Indication, Jordan, 2019-2020
Figure 37: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Jordan, 2019-2020
Figure 38: Medical Devices Clinical Trials Count by Trial Status, Jordan, 2019-2020
Figure 39: Medical Devices Clinical Trials Count by Device Category, Jordan, 2019-2020
Figure 40: Medical Devices Clinical Trials Count by Indication, Jordan, 2019-2020
Figure 41: Top Five Medical Devices Clinical Trials Sponsors by Count, Jordan, 2019-2020
Figure 42: Healthcare Policy Highlights, Jordan
Figure 43: Number of Hospital Beds, Jordan, 2010-2018
Figure 44: Number of Diagnostic Equipment Units (per 10,00,000 Population), Jordan, 2010-2018
Figure 45: Life Expectancy at Birth (Years), Jordan, 2010-2018
Figure 46: Immunization Rate (%), Jordan, 2010-2018
Figure 47: PM2.5 (µg per m3), Jordan, 2010-2017
Figure 48: CO2 Emissions (Mt CO2), Jordan, 2010-2018
Figure 49: Physicians (per 10,000 Population), Jordan, 2010-2018
Figure 50: Dentists (per 10,000 Population), Jordan, 2010-2018
Figure 51: Nurses (per 10,000 Population), Jordan, 2010-2018
Figure 52: Pharmacists (per 10,000 Population), Jordan, 2010-2018
Figure 53: Major Causes of Mortality (Number of Deaths, ‘000), Jordan, 2017
Figure 54: Major Causes of Male Mortality (Number of Deaths, ‘000), Jordan, 2017
Figure 55: Major Causes of Female Mortality (Number of Deaths, ‘000), Jordan, 2017
Figure 56: Disability-Adjusted Life Years by Major Disease (‘000), Jordan, 2016
Figure 57: Healthcare Expenditure as Percentage of GDP (%), Jordan, 2010-2019
Figure 58: Public-Private Share (%), Jordan, 2010-2019
Figure 59: Opportunities and Challenges

この商品のレポートナンバー

0000028596

TOP